What were JOJO Ltd's latest quarterly results?
JOJO Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +7883.3%
- Revenue Growth YoY: +781.1%
- Operating Margin: 48.1%
JOJO Ltd (Pharma - Others) — fundamental analysis, earnings data, and key metrics. PE: 132.0. ROE: 11.6%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
JOJO Ltd's latest quarterly results (Mar 2026) show
JOJO Ltd's current PE ratio is 132.0x.
JOJO Ltd's price-to-book ratio is 10.1x.
JOJO Ltd's fundamental strength based on key financial ratios
JOJO Ltd has a debt-to-equity ratio of N/A.
JOJO Ltd's return ratios over recent years
JOJO Ltd's operating cash flow is positive (FY2026).
JOJO Ltd's current dividend yield is 0.02%.
JOJO Ltd's shareholding pattern (Mar 2026)
JOJO Ltd's promoter holding has remained stable recently.
JOJO Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why JOJO Ltd may be worth studying
JOJO Ltd investment thesis summary:
JOJO Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.